Shared and Drug-Specific Effects of Atomoxetine and Methylphenidate on Inhibitory Brain Dysfunction in Medication-Naive ADHD Boys

The stimulant methylphenidate (MPX) and the nonstimulant atomoxetine (ATX) are the most commonly prescribed medications for attention deficit hyperactivity disorder (ADHD). However, no functional magnetic resonance imaging (fMRI) study has as yet investigated the effects of ATX on inhibitory or any other brain function in ADHD patients or compared its effects with those of MPX. A randomized, double-blind, placebo-controlled, crossover pharmacological design was used to compare the neurofunctional effects of single doses of MPX, ATX, and placebo during a stop task, combined with fMRI within 19 medication-naive ADHD boys, and their potential normalization effects relative to 29 age-matched healthy boys. Compared with controls, ADHD boys under placebo showed bilateral ventrolateral prefrontal, middle temporal, and cerebellar underactivation. Within patients, MPX relative to ATX and placebo significantly upregulated right ventrolateral prefrontal activation, which correlated with enhanced inhibitory capacity. Relative to controls, both drugs significantly normalized the left ventrolateral prefrontal underactivation observed under placebo, while MPX had a drug-specific effect of normalizing right ventrolateral prefrontal and cerebellar underactivation observed under both placebo and ATX. The findings show shared and drug-specific effects of MPX and ATX on performance and brain activation during inhibitory control in ADHD patients with superior upregulation and normalization effects of MPX.

[1]  John O. Willis,et al.  Wechsler Abbreviated Scale of Intelligence , 2014 .

[2]  Janet B W Williams,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[3]  H. Möller,et al.  Methylphenidate effects on neural activity during response inhibition in healthy humans. , 2013, Cerebral cortex.

[4]  Steven C. R. Williams,et al.  Methylphenidate Effects on Prefrontal Functioning During Attentional-Capture and Response Inhibition , 2012, Biological Psychiatry.

[5]  G. Sartori,et al.  Striatal dopamine transporter alterations in ADHD: pathophysiology or adaptation to psychostimulants? A meta-analysis. , 2012, The American journal of psychiatry.

[6]  R. Halari,et al.  A review of fronto-striatal and fronto-cortical brain abnormalities in children and adults with Attention Deficit Hyperactivity Disorder (ADHD) and new evidence for dysfunction in adults with ADHD during motivation and attention , 2012, Cortex.

[7]  N. Skokauskas,et al.  Meta‐analysis of structural MRI studies in children and adults with attention deficit hyperactivity disorder indicates treatment effects , 2012, Acta psychiatrica Scandinavica.

[8]  P. Hazell,et al.  How Oppositionality, Inattention, and Hyperactivity Affect Response to Atomoxetine Versus Methylphenidate , 2011, Journal of attention disorders.

[9]  R. Hanwella,et al.  Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis , 2011, BMC psychiatry.

[10]  Katya Rubia,et al.  Gray matter volume abnormalities in ADHD: voxel-based meta-analysis exploring the effects of age and stimulant medication. , 2011, The American journal of psychiatry.

[11]  P. Hazell,et al.  Core ADHD Symptom Improvement With Atomoxetine Versus Methylphenidate , 2011, Journal of attention disorders.

[12]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[13]  Rozmin Halari,et al.  Methylphenidate Normalizes Frontocingulate Underactivation During Error Processing in Attention-Deficit/Hyperactivity Disorder , 2011, Biological Psychiatry.

[14]  Natalia del Campo,et al.  The Roles of Dopamine and Noradrenaline in the Pathophysiology and Treatment of Attention-Deficit/Hyperactivity Disorder , 2011, Biological Psychiatry.

[15]  Katya Rubia,et al.  “Cool” Inferior Frontostriatal Dysfunction in Attention-Deficit/Hyperactivity Disorder Versus “Hot” Ventromedial Orbitofrontal-Limbic Dysfunction in Conduct Disorder: A Review , 2011, Biological Psychiatry.

[16]  B. Abler,et al.  Neural Correlates of Error Monitoring Modulated by Atomoxetine in Healthy Volunteers , 2011, Biological Psychiatry.

[17]  Jason B. Mattingley,et al.  Methylphenidate But Not Atomoxetine or Citalopram Modulates Inhibitory Control and Response Time Variability , 2011, Biological Psychiatry.

[18]  M. Brammer,et al.  Methylphenidate Normalizes Fronto-Striatal Underactivation During Interference Inhibition in Medication-Naïve Boys with Attention-Deficit Hyperactivity Disorder , 2011, Neuropsychopharmacology.

[19]  Rozmin Halari,et al.  Disorder‐specific inferior prefrontal hypofunction in boys with pure attention‐deficit/hyperactivity disorder compared to boys with pure conduct disorder during cognitive flexibility , 2010, Human brain mapping.

[20]  Richard E. Carson,et al.  Clinically Relevant Doses of Methylphenidate Significantly Occupy Norepinephrine Transporters in Humans In Vivo , 2010, Biological Psychiatry.

[21]  Maneesh C. Patel,et al.  Distinct frontal systems for response inhibition, attentional capture, and error processing , 2010, Proceedings of the National Academy of Sciences.

[22]  Katya Rubia,et al.  Disorder‐specific dysfunction in right inferior prefrontal cortex during two inhibition tasks in boys with attention‐deficit hyperactivity disorder compared to boys with obsessive–compulsive disorder , 2009, Human brain mapping.

[23]  Rozmin Halari,et al.  Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task , 2009, Neuropharmacology.

[24]  Hongtu Zhu,et al.  An FMRI study of the effects of psychostimulants on default-mode processing during Stroop task performance in youths with ADHD. , 2009, The American journal of psychiatry.

[25]  A. MacDonald,et al.  The neural basis of cognitive control: Response selection and inhibition , 2009, Brain and Cognition.

[26]  J. Alda,et al.  Evaluation of atomoxetine for first-line treatment of newly diagnosed, treatment-naïve children and adolescents with attention deficit/hyperactivity disorder , 2009, Current medical research and opinion.

[27]  R. Halari,et al.  Impulsiveness as a timing disturbance: neurocognitive abnormalities in attention-deficit hyperactivity disorder during temporal processes and normalization with methylphenidate , 2009, Philosophical Transactions of the Royal Society B: Biological Sciences.

[28]  M. Barnes,et al.  Why IQ is not a covariate in cognitive studies of neurodevelopmental disorders , 2009, Journal of the International Neuropsychological Society.

[29]  M. Bellgrove,et al.  Insights into the neural basis of response inhibition from cognitive and clinical neuroscience , 2009, Neuroscience & Biobehavioral Reviews.

[30]  T. Robbins,et al.  Atomoxetine Modulates Right Inferior Frontal Activation During Inhibitory Control: A Pharmacological Functional Magnetic Resonance Imaging Study , 2009, Biological Psychiatry.

[31]  V. Calhoun,et al.  Brain network dynamics during error commission , 2009, Human brain mapping.

[32]  Rozmin Halari,et al.  Disorder-specific dissociation of orbitofrontal dysfunction in boys with pure conduct disorder during reward and ventrolateral prefrontal dysfunction in boys with pure ADHD during sustained attention. , 2009, The American journal of psychiatry.

[33]  L. Senelick.  It (review) , 2008 .

[34]  A. Turken,et al.  Left inferior frontal gyrus is critical for response inhibition , 2008, BMC Neuroscience.

[35]  Danielle C. Turner,et al.  Methylphenidate improves response inhibition but not reflection–impulsivity in children with attention deficit hyperactivity disorder (ADHD) , 2008, Psychopharmacology.

[36]  Vincent Giampietro,et al.  Dissociated functional brain abnormalities of inhibition in boys with pure conduct disorder and in boys with pure attention deficit hyperactivity disorder. , 2008, The American journal of psychiatry.

[37]  R. Schachar,et al.  Dissociation of response inhibition and performance monitoring in the stop signal task using event‐related fMRI , 2007, Human brain mapping.

[38]  G. Fink,et al.  Long-term effects of methylphenidate on neural networks associated with executive attention in children with ADHD: results from a longitudinal functional MRI study. , 2007, Journal of the American Academy of Child and Adolescent Psychiatry.

[39]  T. Robbins,et al.  Atomoxetine Improved Response Inhibition in Adults with Attention Deficit/Hyperactivity Disorder , 2007, Biological Psychiatry.

[40]  M. Brammer,et al.  Linear age‐correlated functional development of right inferior fronto‐striato‐cerebellar networks during response inhibition and anterior cingulate during error‐related processes , 2007, Human brain mapping.

[41]  Godfrey D Pearlson,et al.  An FMRI auditory oddball study of combined-subtype attention deficit hyperactivity disorder. , 2007, The American journal of psychiatry.

[42]  Michael J. Brammer,et al.  Temporal Lobe Dysfunction in Medication-Naïve Boys With Attention-Deficit/Hyperactivity Disorder During Attention Allocation and Its Relation to Response Variability , 2007, Biological Psychiatry.

[43]  G. Logan,et al.  Converging Evidence for a Fronto-Basal-Ganglia Network for Inhibitory Control of Action and Cognition , 2007, The Journal of Neuroscience.

[44]  Keith M. Shafritz,et al.  ADHD- and medication-related brain activation effects in concordantly affected parent-child dyads with ADHD. , 2007, Journal of child psychology and psychiatry, and allied disciplines.

[45]  Michael J. Kofler,et al.  Attention-Deficit/Hyperactivity Disorder and Behavioral Inhibition: A Meta-Analytic Review of the Stop-signal Paradigm , 2007, Journal of abnormal child psychology.

[46]  Jean-Baptiste Poline,et al.  Analysis of a large fMRI cohort: Statistical and methodological issues for group analyses , 2007, NeuroImage.

[47]  J. Jonides,et al.  Interference resolution: Insights from a meta-analysis of neuroimaging tasks , 2007, Cognitive, affective & behavioral neuroscience.

[48]  H. Engeland,et al.  Dose-related effect of methylphenidate on stopping and changing in children with attention-deficit/hyperactivity disorder , 2006, European Psychiatry.

[49]  Brian Toone,et al.  Task-specific hypoactivation in prefrontal and temporoparietal brain regions during motor inhibition and task switching in medication-naive children and adolescents with attention deficit hyperactivity disorder. , 2006, The American journal of psychiatry.

[50]  Vinod Menon,et al.  Parietal attentional system aberrations during target detection in adolescents with attention deficit hyperactivity disorder: event-related fMRI evidence. , 2006, The American journal of psychiatry.

[51]  D. Bridgett,et al.  Intellectual functioning in adults with ADHD: a meta-analytic examination of full scale IQ differences between adults with and without ADHD. , 2006, Psychological assessment.

[52]  Jinhu Xiong,et al.  Neuroimaging of inhibitory control areas in children with attention deficit hyperactivity disorder who were treatment naive or in long-term treatment. , 2006, The American journal of psychiatry.

[53]  Robin M. Murray,et al.  The Maudsley Handbook of Practical Psychiatry , 2006 .

[54]  R. Poldrack,et al.  Cortical and Subcortical Contributions to Stop Signal Response Inhibition: Role of the Subthalamic Nucleus , 2006, The Journal of Neuroscience.

[55]  Jason B. Mattingley,et al.  Executive “Brake Failure” following Deactivation of Human Frontal Lobe , 2006, Journal of Cognitive Neuroscience.

[56]  Jonathan D. Cohen,et al.  An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance. , 2005, Annual review of neuroscience.

[57]  M. Brammer,et al.  Abnormal brain activation during inhibition and error detection in medication-naive adolescents with ADHD. , 2005, The American journal of psychiatry.

[58]  M G Woldorff,et al.  Hemispheric asymmetries for different components of global/local attention occur in distinct temporo-parietal loci. , 2005, Cerebral cortex.

[59]  M. Brass,et al.  Involvement of the inferior frontal junction in cognitive control: Meta‐analyses of switching and Stroop studies , 2005, Human brain mapping.

[60]  Keith M. Shafritz,et al.  The effects of methylphenidate on neural systems of attention in attention deficit hyperactivity disorder. , 2004, The American journal of psychiatry.

[61]  T. Robbins,et al.  Inhibition and the right inferior frontal cortex , 2004, Trends in Cognitive Sciences.

[62]  M. Behrmann,et al.  Parietal cortex and attention , 2004, Current Opinion in Neurobiology.

[63]  B. Herpertz-Dahlmann,et al.  Differential effects of methylphenidate on attentional functions in children with attention-deficit/hyperactivity disorder. , 2004, Journal of the American Academy of Child and Adolescent Psychiatry.

[64]  S. Haber.  The primate basal ganglia: parallel and integrative networks , 2003, Journal of Chemical Neuroanatomy.

[65]  Katya Rubia,et al.  Right inferior prefrontal cortex mediates response inhibition while mesial prefrontal cortex is responsible for error detection , 2003, NeuroImage.

[66]  G. Logan,et al.  Selective Inhibition in Children with Attention-Deficit Hyperactivity Disorder Off and On Stimulant Medication , 2003, Journal of abnormal child psychology.

[67]  C. Berridge,et al.  The locus coeruleus–noradrenergic system: modulation of behavioral state and state-dependent cognitive processes , 2003, Brain Research Reviews.

[68]  Sharon Morein-Zamir,et al.  The Effect of Methylphenidate on Three Forms of Response Inhibition in Boys with AD/HD , 2003, Journal of abnormal child psychology.

[69]  T. Robbins,et al.  Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans , 2003, Nature Neuroscience.

[70]  J. Biederman,et al.  Atomoxetine pharmacokinetics in children and adolescents with attention deficit hyperactivity disorder. , 2003, Journal of child and adolescent psychopharmacology.

[71]  K. Perry,et al.  Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat: A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder , 2002, Neuropsychopharmacology.

[72]  M. Corbetta,et al.  Control of goal-directed and stimulus-driven attention in the brain , 2002, Nature Reviews Neuroscience.

[73]  J. Downar,et al.  A cortical network sensitive to stimulus salience in a neutral behavioral context across multiple sensory modalities. , 2002, Journal of neurophysiology.

[74]  G. A. Miller,et al.  Misunderstanding analysis of covariance. , 2001, Journal of abnormal psychology.

[75]  T A Carpenter,et al.  Colored noise and computational inference in neurophysiological (fMRI) time series analysis: Resampling methods in time and wavelet domains , 2001, Human brain mapping.

[76]  H. Kraemer,et al.  Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial. , 2001, Journal of the American Academy of Child and Adolescent Psychiatry.

[77]  E. Bullmore,et al.  Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: a study with functional MRI. , 1999, The American journal of psychiatry.

[78]  S C Williams,et al.  Quality control for functional magnetic resonance imaging using automated data analysis and Shewhart charting , 1999, Magnetic resonance in medicine.

[79]  Robert Goodman,et al.  Comparing the Strengths and Difficulties Questionnaire and the Child Behavior Checklist: Is Small Beautiful? , 1999, Journal of abnormal child psychology.

[80]  John Suckling,et al.  Global, voxel, and cluster tests, by theory and permutation, for a difference between two groups of structural MR images of the brain , 1999, IEEE Transactions on Medical Imaging.

[81]  E. Bullmore,et al.  Methods for diagnosis and treatment of stimulus‐correlated motion in generic brain activation studies using fMRI , 1999, Human brain mapping.

[82]  G H Glover,et al.  Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[83]  N. Volkow,et al.  Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. , 1998, The American journal of psychiatry.

[84]  J. Epstein,et al.  Revision and Restandardization of the Conners Teacher Rating Scale (CTRS-R): Factor Structure, Reliability, and Criterion Validity , 1998, Journal of abnormal child psychology.

[85]  S C Williams,et al.  Generic brain activation mapping in functional magnetic resonance imaging: a nonparametric approach. , 1997, Magnetic resonance imaging.

[86]  D G Altman,et al.  Statistics Notes: Interaction 2: compare effect sizes not P values , 1996, BMJ.

[87]  G. Dickie,et al.  Statistics notes , 1994 .

[88]  Dc Washington.  Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. , 1994 .

[89]  J. Rabe-Jabłońska,et al.  [Affective disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association -- diagnostic and statistical manual of mental disorders]. , 1993, Psychiatria polska.

[90]  Gordon D. Logan,et al.  Effects of methylphenidate on inhibitory control in hyperactive children , 1989, Journal of abnormal child psychology.

[91]  P. C. Murphy,et al.  Cerebral Cortex , 2017, Cerebral Cortex.

[92]  P. A. Williamson,et al.  Asymmetric neural control systems in human self-regulation. , 1984, Psychological review.

[93]  J. Thiessen,et al.  Methylphenidate hydrochloride given with or before breakfast , 1983 .

[94]  J. Thiessen,et al.  Methylphenidate hydrochloride given with or before breakfast: II. Effects on plasma concentration of methylphenidate and ritalinic acid. , 1983, Pediatrics.